“…However, the disease-retarding role of homozygosity for the CXCL12-3'A allele has not been confirmed in other cohorts (Mummidi et al, 1998;Wang et al, 2003;van Rij et al, 1998;Magierowska et al, 1999;Rousset et al, 1999;Brambilla et al, 2000;Soriano et al, 2002). Verma et al (2007) observed a low frequency of CCR5-Δ32 (1.5%) and of CCR2-64I (9.1%) in healthy Northern Indians, suggesting high vulnerability of North Indians to HIV-1 infection. However, the allelic frequency of the CXCL12 3'A was high (20.4%) in the healthy HIV-1 seronegative Northern Indians included in their study, which was similar to that observed in South Indians (17.0%-35.0%) and South European populations (14.0%-33.0%) (Ramana et al, 2001).…”